{"disease":{"id":"burn-scar-itch","name":"Burn Scar Itch","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":1,"trial_count":0},"drugs":{"marketed":[],"pipeline":[{"drug_id":"cromolyn-sodium","indication_name":"Burn Scar Itch","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CROMOLYN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"Mast cells","drug_class":"Mast cell stabilizer","quality_score":30,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT06801626","title":"Novel Strategies for Reducing Burn Scar Itch","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"The University of Texas Medical Branch, Galveston","has_results":false},{"nct_id":"NCT07020507","title":"Exploratory Study to Evaluate the Efficacy of the Cosmetic Product RV3895A on Re-epidermised Scars Following Burns and Surgical Stitches in Adults, Adolescents and Children Over a 6-month Follow-up Period","phase":"","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Pierre Fabre Dermo Cosmetique","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}